首页> Cancer cell> Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies.

Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies.

导出 OA

翻译打印收藏纠错

第一作者： Roberta,Zappasodi

第一单位： Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

作者： Roberta,Zappasodi ^[1] ; Taha,Merghoub ^[2] ; Jedd D,Wolchok ^[3]

作者单位： Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. ^[1] Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: merghout@mskcc.org. ^[2] Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: wolchokj@mskcc.org. ^[3]

关键词 cancer immunotherapy immune checkpoint blockade immunotherapy-based combinations tumor immunology

医学主题词抗体, 封闭(Antibodies, Blocking);临床试验(主题)(Clinical Trials as Topic);综合疗法(Combined Modality Therapy);人类(Humans);免疫疗法(Immunotherapy);肿瘤(Neoplasms);肿瘤负荷(Tumor Burden)

DOI 10.1016/j.ccell.2018.03.005

PMID 29634946

发布时间 2021-01-09

基金项目

P30 CA008748/CA/NCI NIH HHS/United States

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交